Cargando…
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147428/ https://www.ncbi.nlm.nih.gov/pubmed/32243307 http://dx.doi.org/10.1097/LGT.0000000000000525 |
_version_ | 1783520419266953216 |
---|---|
author | Perkins, Rebecca B. Guido, Richard S. Castle, Philip E. Chelmow, David Einstein, Mark H. Garcia, Francisco Huh, Warner K. Kim, Jane J. Moscicki, Anna-Barbara Nayar, Ritu Saraiya, Mona Sawaya, George F. Wentzensen, Nicolas Schiffman, Mark |
author_facet | Perkins, Rebecca B. Guido, Richard S. Castle, Philip E. Chelmow, David Einstein, Mark H. Garcia, Francisco Huh, Warner K. Kim, Jane J. Moscicki, Anna-Barbara Nayar, Ritu Saraiya, Mona Sawaya, George F. Wentzensen, Nicolas Schiffman, Mark |
author_sort | Perkins, Rebecca B. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7147428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-71474282020-04-24 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Perkins, Rebecca B. Guido, Richard S. Castle, Philip E. Chelmow, David Einstein, Mark H. Garcia, Francisco Huh, Warner K. Kim, Jane J. Moscicki, Anna-Barbara Nayar, Ritu Saraiya, Mona Sawaya, George F. Wentzensen, Nicolas Schiffman, Mark J Low Genit Tract Dis Risk Based Guidelines Lippincott Williams & Wilkins 2020-04-02 /pmc/articles/PMC7147428/ /pubmed/32243307 http://dx.doi.org/10.1097/LGT.0000000000000525 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCCP. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Risk Based Guidelines Perkins, Rebecca B. Guido, Richard S. Castle, Philip E. Chelmow, David Einstein, Mark H. Garcia, Francisco Huh, Warner K. Kim, Jane J. Moscicki, Anna-Barbara Nayar, Ritu Saraiya, Mona Sawaya, George F. Wentzensen, Nicolas Schiffman, Mark 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
title | 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
title_full | 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
title_fullStr | 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
title_full_unstemmed | 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
title_short | 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors |
title_sort | 2019 asccp risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors |
topic | Risk Based Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147428/ https://www.ncbi.nlm.nih.gov/pubmed/32243307 http://dx.doi.org/10.1097/LGT.0000000000000525 |
work_keys_str_mv | AT perkinsrebeccab 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT guidorichards 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT castlephilipe 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT chelmowdavid 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT einsteinmarkh 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT garciafrancisco 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT huhwarnerk 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT kimjanej 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT moscickiannabarbara 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT nayarritu 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT saraiyamona 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT sawayageorgef 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT wentzensennicolas 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors AT schiffmanmark 2019asccpriskbasedmanagementconsensusguidelinesforabnormalcervicalcancerscreeningtestsandcancerprecursors |